Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Integra LifeSciences Holdings Corporation - Common Stock (NQ:IART)

16.35 +0.08 (+0.49%)
Streaming Delayed Price Updated: 12:53 PM EDT, Sep 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Integra LifeSciences Holdings Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
News headline image
1 of Wall Street’s Favorite Stocks with Impressive Fundamentals and 2 We Turn Down
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic... 
Via StockStory
News headline image
3 Reasons IART is Risky and 1 Stock to Buy Instead
What a time it’s been for Integra LifeSciences. In the past six months alone, the company’s stock price has increased by a massive 70.2%, reaching $16.26 per... 
Via StockStory
Topics Bankruptcy
News headline image
Q2 Earnings Outperformers: Integra LifeSciences (NASDAQ:IART) And The Rest Of The Surgical Equipment & Consumables - Specialty Stocks
Let’s dig into the relative performance of Integra LifeSciences (NASDAQ:IART) and its peers as we unravel the now-completed Q2 surgical equipment & consumabl... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
3 Cash-Producing Stocks That Fall Short
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
Via StockStory
Topics Firearms
Integra LifeSciences (NASDAQ:IART) Surges Over 30% on Q2 Earnings Beat ↗
Via Chartmill
News headline image
3 Profitable Stocks We Think Twice About
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does... 
Via StockStory
News headline image
3 Stocks Under $50 with Questionable Fundamentals
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha... 
Via StockStory
News headline image
3 Value Stocks We Steer Clear Of
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ... 
Via StockStory
News headline image
2 Russell 2000 Stocks with Solid Fundamentals and 1 We Find Risky
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,... 
Via StockStory
News headline image
Integra (IART) Q2 2026 Earnings Call Transcript ↗
Manufacturing restart and margin gains drive stabilization as company pursues deleveraging. 
Via The Motley Fool
Topics Earnings World Trade
News headline image
5 Must-Read Analyst Questions From Integra LifeSciences’s Q2 Earnings Call
Integra LifeSciences’ second quarter results reflected ongoing business challenges, as management attributed the quarter’s flat revenue to ongoing reimbursem... 
Via StockStory
Topics Earnings World Trade
News headline image
IART Q2 Deep Dive: Flat Revenue, Margin Pressure, and Operational Realignment Shape Outlook
Medical device company Integra LifeSciences (NASDAQ:IART) met Wall Street’s revenue expectations in Q2 CY2026, but sales were flat year on year at $418.8 mil... 
Via StockStory
Topics World Trade
News headline image
Why Integra LifeSciences (IART) Shares Are Sliding Today
What Happened? Shares of medical device company Integra LifeSciences (NASDAQ:IART) fell 10.1% in the afternoon session after the company reported a second-qu... 
Via StockStory
Topics Earnings
News headline image
Integra LifeSciences Q2 Earnings Call Highlights ↗
Integra LifeSciences (NASDAQ:IART) reported second-quarter 2026 revenue of $419 million, up 0.8% on a reported basis and 0.7% organically from a year earlier, as improving supply reliability and... 
Via MarketBeat
Topics Earnings World Trade
News headline image
Integra LifeSciences’s (NASDAQ:IART) Q2 CY2026 Earnings Results: Revenue In Line With Expectations
Medical device company Integra LifeSciences (NASDAQ:IART) met Wall Street’s revenue expectations in Q2 CY2026, but sales were flat year on year at $418.8 mil... 
Via StockStory
News headline image
Integra LifeSciences (IART) To Report Earnings Tomorrow: Here Is What To Expect
Medical device company Integra LifeSciences (NASDAQ:IART) will be announcing earnings results this Wednesday morning. Here’s what to look for. Integra LifeSc... 
Via StockStory
Topics Artificial Intelligence
News headline image
1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as... 
Via StockStory
News headline image
Kaskela Law Firm Announces Investigation of Integra LifeSciences (IART) and Encourages Long-Term IART Shareholders with Investment Losses to Contact the Firm
From Kaskela Law LLC
Via Business Wire
News headline image
3 Small-Cap Stocks with Warning Signs
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ... 
Via StockStory
News headline image
Why Integra LifeSciences (IART) Stock Is Up Today
What Happened? Shares of medical device company Integra LifeSciences (NASDAQ:IART) jumped 4.3% in the afternoon session after BMO Capital initiated coverage ... 
Via StockStory
Topics Artificial Intelligence Earnings
News headline image
3 Unpopular Stocks with Open Questions
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad t... 
Via StockStory
News headline image
1 Value Stock to Target This Week and 2 We Brush Off
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ... 
Via StockStory
Topics Economy
News headline image
Surgical Equipment & Consumables - Specialty Stocks Q1 Results: Benchmarking Integra LifeSciences (NASDAQ:IART)
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself
From Biotech Insider
Via GlobeNewswire
News headline image
The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It
From World Street Intelligence
Via GlobeNewswire
News headline image
3 Profitable Stocks We’re Skeptical Of
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ... 
Via StockStory
News headline image
A Fresh FDA Catalyst Is Putting Regenerative Wound Care in Focus
Issued on behalf of Conexeu Sciences Inc. 
From Equity Insider
Via GlobeNewswire
News headline image
3 Reasons to Avoid IART and 1 Stock to Buy Instead
Over the past six months, Integra LifeSciences has been a great trade, beating the S&P 500 by 25.3%. Its stock price has climbed to $17.91, representing a he... 
Via StockStory
Topics Bankruptcy Stocks
News headline image
Why Integra LifeSciences (IART) Stock Is Trading Up Today
What Happened? Shares of medical device company Integra LifeSciences (NASDAQ:IART) jumped 6.1% in the afternoon session after Citigroup upgraded its rating o... 
Via StockStory
News headline image
3 Inflated Stocks That Concern Us
The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, u... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.